# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA510103 | 2 | Activity | 0 | ALA4048759 | Active | Homo sapiens | |||||
2. | ALA510103 | 2 | Activity | 0 | ALA4728755 | Toxic | Homo sapiens | |||||
3. | ALA510103 | 2 | Activity | 0 | ALA4728754 | Non-Toxic | Homo sapiens | |||||
4. | ALA510103 | 2 | INH | = | 6.5 | % | ALA3123290 | % | Glycine max | |||
5. | ALA510103 | 2 | INH | = | 80 | % | ALA3124570 | % | Human immunodeficiency virus 1 | |||
6. | ALA510103 | 2 | Drug uptake | 0 | ALA1821140 | Active | Homo sapiens | |||||
7. | ALA510103 | 2 | Ratio CC50/IC50 | > | 13 | ALA1027471 | ||||||
8. | ALA510103 | 2 | IC50 | = | 2.5 | uM | ALA1027472 | 5.60 | nM | Human immunodeficiency virus 1 | ||
9. | ALA510103 | 2 | CC50 | = | 33.8 | uM | ALA1027473 | nM | ||||
10. | ALA510103 | 2 | Activity | 0 | ALA940480 | Not Active | ||||||
11. | ALA510103 | 2 | Activity | 0 | ALA940479 | Not Active | ||||||
12. | ALA510103 | 2 | Activity | 0 | ALA940478 | Active | ||||||
13. | ALA510103 | 2 | Activity | 0 | ALA940477 | Active | ||||||
14. | ALA510103 | 2 | ED50 | = | 1.6 | ug ml-1 | ALA940472 | ug ml-1 | Homo sapiens | |||
15. | ALA510103 | 2 | ED50 | = | 1.5 | ug ml-1 | ALA940469 | ug ml-1 | Homo sapiens | |||
16. | ALA510103 | 2 | ED50 | = | 1.5 | ug ml-1 | ALA940468 | ug ml-1 | Homo sapiens | |||
17. | ALA510103 | 2 | FC | = | 1.1 | ALA940476 | Homo sapiens | |||||
18. | ALA510103 | 2 | FC | = | 1 | ALA940474 | Homo sapiens | |||||
19. | ALA510103 | 2 | ED50 | = | 0.91 | ug ml-1 | ALA940473 | ug ml-1 | Homo sapiens | |||
20. | ALA510103 | 2 | ED50 | = | 0.88 | ug ml-1 | ALA940470 | ug ml-1 |